Cargando…

Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people

BACKGROUND: There is uncertainty about the associations of angiotensive enzyme (ACE) inhibitor and angiotensin receptor blocker (ARB) drugs with COVID-19 disease. We studied whether patients prescribed these drugs had altered risks of contracting severe COVID-19 disease and receiving associated inte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hippisley-Cox, Julia, Young, Duncan, Coupland, Carol, Channon, Keith M, Tan, Pui San, Harrison, David A, Rowan, Kathryn, Aveyard, Paul, Pavord, Ian D, Watkinson, Peter J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Special Populations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509391/ https://www.ncbi.nlm.nih.gov/pubmed/32737124 http://dx.doi.org/10.1136/heartjnl-2020-317393

Ejemplares similares

Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study
por: Aveyard, Paul, et al.
Publicado: (2021)

Mortality from angiotensin-converting enzyme-inhibitors and angiotensin receptor blockers in people infected with COVID-19: a cohort study of 3.7 million people
por: Dambha-Miller, Hajira, et al.
Publicado: (2022)

Association between smoking, e-cigarette use and severe COVID-19: a cohort study
por: Gao, Min, et al.
Publicado: (2022)

Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study
por: Patone, Martina, et al.
Publicado: (2021)

Mechanisms by which angiotensin-receptor blockers increase ACE2 levels
por: Ferrario, Carlos M., et al.
Publicado: (2020)

Impact of vaccination on COVID-19-associated admissions to critical care in England: a study of population linked data with quantitative bias analysis for linkage error.
por: Harrison, David, et al.
Publicado: (2022)

Ethnic disparities in COVID-19 outcomes: a multinational cohort study of 20 million individuals from England and Canada
por: Zaccardi, Francesco, et al.
Publicado: (2023)

Uptake of COVID-19 vaccination in people with blood cancer: Population-level cohort study of 12 million patients in England
por: Hirst, Jennifer, et al.
Publicado: (2023)

Use of ACE Inhibitors and Angiotensin Receptor Blockers and Primary Breast Cancer Outcomes
por: Chae, Young Kwang, et al.
Publicado: (2013)

ACE-inhibitor/angiotensin receptor blockers (ACE-I/ARBs) therapy in COVID-19 infected dialysis patients
por: Daoud, Ahmed, et al.
Publicado: (2021)

Reply: ACE Inhibitors and Angiotensin II Receptor Blockers May Have Different Impact on Prognosis of COVID-19
por: Amat-Santos, Ignacio J., et al.
Publicado: (2020)

Hypertension and renin-angiotensin system blockers are not associated with expression of angiotensin-converting enzyme 2 (ACE2) in the kidney
por: Jiang, Xiao, et al.
Publicado: (2020)

Validating the QCOVID risk prediction algorithm for risk of mortality from COVID-19 in the adult population in Wales, UK
por: Lyons, Jane, et al.
Publicado: (2022)

Single‐Center Evaluation of the Pharmacokinetics and Safety of the Angiotensin II Receptor Antagonist Azilsartan Medoxomil in Mild to Moderate Hepatic Impairment
por: Dudkowski, Caroline, et al.
Publicado: (2017)

Multisystem inflammatory syndrome in 1.2 million children: longitudinal cohort study of risk factors
por: Auger, Nathalie, et al.
Publicado: (2023)

Comparative effectiveness of ACE inhibitors and angiotensin receptor blockers in patients with prior myocardial infarction
por: Ko, Dennis, et al.
Publicado: (2019)

An epidemiological study exploring a possible impact of treatment with ACE inhibitors or angiotensin receptor blockers on ACE2 plasma concentrations
por: Wild, Philipp S., et al.
Publicado: (2020)

Associations between body-mass index and COVID-19 severity in 6·9 million people in England: a prospective, community-based, cohort study
por: Gao, Min, et al.
Publicado: (2021)

Should ACE Inhibitors and Angiotensin Receptor Blockers Be Withdrawn in the Current Setting of COVID-19 Infection?
por: Manga, Pravin
Publicado: (2020)

Robust ACE2 protein expression localizes to the motile cilia of the respiratory tract epithelia and is not increased by ACE inhibitors or angiotensin receptor blockers
por: Lee, Ivan T., et al.
Publicado: (2020)

The population bomb /
por: Ehrlich, Paul R.
Publicado: (1995)

ACE Inhibitors and Angiotensin II Receptor Blockers May Have Different Impact on Prognosis of COVID-19
por: Wang, Yueying, et al.
Publicado: (2020)

ACE Inhibitor/Angiotensin Receptor Blocker Use Patterns in Advanced CKD and Risk of Kidney Failure and Death
por: Arora, Nayan, et al.
Publicado: (2020)

Probabilistic linkage of national immunisation and state-based health records for a cohort of 1.9 million births to evaluate Australia's childhood immunisation program
por: Gidding, HF, et al.
Publicado: (2017)

Association of ACE inhibitors and angiotensin type II blockers with ACE2 overexpression in COVID-19 comorbidities: A pathway-based analytical study
por: Parit, Rahul, et al.
Publicado: (2021)

Smoking and COVID-19 outcomes: an observational and Mendelian randomisation study using the UK Biobank cohort
por: Clift, Ashley K, et al.
Publicado: (2022)

Angiotensin-converting-enzyme inhibitors (ACE inhibitors) and angiotensin II receptor blocker (ARB) use in COVID-19 prevention or treatment: A paradox
por: Javanmard, Shaghayegh Haghjooy, et al.
Publicado: (2020)

Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers (ARB) Are Protective Against ICU Admission and Mortality for Patients With COVID-19 Disease
por: ElAbd, Rawan, et al.
Publicado: (2021)

RU28318, an Aldosterone Antagonist, in Combination with an ACE Inhibitor and Angiotensin Receptor Blocker Attenuates Cardiac Dysfunction in Diabetes
por: Benter, Ibrahim F., et al.
Publicado: (2013)

Associations between ACE-Inhibitors, Angiotensin Receptor Blockers, and Lean Body Mass in Community Dwelling Older Women
por: Bea, Jennifer W., et al.
Publicado: (2018)

Effect of ACE inhibitors and angiotensin receptor blockers on in-hospital mortality and length of stay in hospitalized COVID-19 patients
por: LaClair, Heather J., et al.
Publicado: (2021)

Early warning signal reliability varies with COVID-19 waves
por: O'Brien, Duncan A., et al.
Publicado: (2021)

Development and validation of risk prediction algorithm (QThrombosis) to estimate future risk of venous thromboembolism: prospective cohort study
por: Hippisley-Cox, Julia, et al.
Publicado: (2011)

Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database
por: Hippisley-Cox, Julia, et al.
Publicado: (2010)

Identifying women with suspected ovarian cancer in primary care: derivation and validation of algorithm
por: Hippisley-Cox, Julia, et al.
Publicado: (2012)

Predicting the risk of Chronic Kidney Disease in Men and Women in England and Wales: prospective derivation and external validation of the QKidney(® )Scores
por: Hippisley-Cox, Julia, et al.
Publicado: (2010)

Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScores
por: Hippisley-Cox, Julia, et al.
Publicado: (2009)

Predicting risk of upper gastrointestinal bleed and intracranial bleed with anticoagulants: cohort study to derive and validate the QBleed scores
por: Hippisley-Cox, Julia, et al.
Publicado: (2014)

Predicting risk of emergency admission to hospital using primary care data: derivation and validation of QAdmissions score
por: Hippisley-Cox, Julia, et al.
Publicado: (2013)

Development and validation of risk prediction equations to estimate future risk of heart failure in patients with diabetes: a prospective cohort study
por: Hippisley-Cox, Julia, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ro81kc62m4v56866il1bf76m7l